Cytoplasmic OCT4 staining is a sensitive marker of neuroendocrine differentiation

Riley E. Alexander, Liang Cheng, David J. Grignon, Muhammad T. Idrees

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Summary Previous studies by the authors have described a novel cytoplasmic staining pattern with OCT4 in normal adrenal medullary tissue and in paragangliomas. We aimed to determine if this type of staining is found in other neuroendocrine tissues by examining a broad range of neuroendocrine tumors. Fifty neuroendocrine tumors of various grades and primary organ sites were selected. All cases were immunostained with OCT4 and Ki-67. OCT4 reactivity was then scored for intensity (0-3+) and extent (0-3+). Ki-67 proliferation index was scored as a percentage of total tumor cells. Immunoelectron microscopy was performed to determine precise location of antibody binding within cells. Immunoreactivity was seen in 26 (96%) of 27 cases of carcinoid tumors. The same type of strong staining was seen in 4 (67%) of 6 moderately differentiated neuroendocrine tumors. Only 2 (12%) of 17 poorly differentiated neuroendocrine tumors showed similar staining. A strong, inverse correlation was seen with OCT4 and Ki-67 index. Immunoelectron microscopy showed binding of OCT4 antibody to neurosecretory granules. Cytoplasmic staining of OCT4 is a sensitive marker of neuroendocrine differentiation that has yet to be described in any other tissue or tumor type. These findings show that this antibody has a high affinity for well- to moderately differentiated neuroendocrine tumors. Although comparative studies with other markers and a more extensive analysis of other tissue types are necessary, cytoplasmic staining of OCT4 may prove to be a useful immunostain in the diagnosis of neuroendocrine tumors.

Original languageEnglish (US)
Pages (from-to)27-32
Number of pages6
JournalHuman pathology
Volume45
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Neuroendocrine Tumors
Differentiation Antigens
Staining and Labeling
Immunoelectron Microscopy
Antibodies
Paraganglioma
Carcinoid Tumor
Neoplasms

Keywords

  • Carcinoid
  • Neuroendocrine tumors
  • OCT4
  • Small cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cytoplasmic OCT4 staining is a sensitive marker of neuroendocrine differentiation. / Alexander, Riley E.; Cheng, Liang; Grignon, David J.; Idrees, Muhammad T.

In: Human pathology, Vol. 45, No. 1, 01.01.2014, p. 27-32.

Research output: Contribution to journalArticle

@article{3809ec9363494c01b174a6702ea76d51,
title = "Cytoplasmic OCT4 staining is a sensitive marker of neuroendocrine differentiation",
abstract = "Summary Previous studies by the authors have described a novel cytoplasmic staining pattern with OCT4 in normal adrenal medullary tissue and in paragangliomas. We aimed to determine if this type of staining is found in other neuroendocrine tissues by examining a broad range of neuroendocrine tumors. Fifty neuroendocrine tumors of various grades and primary organ sites were selected. All cases were immunostained with OCT4 and Ki-67. OCT4 reactivity was then scored for intensity (0-3+) and extent (0-3+). Ki-67 proliferation index was scored as a percentage of total tumor cells. Immunoelectron microscopy was performed to determine precise location of antibody binding within cells. Immunoreactivity was seen in 26 (96{\%}) of 27 cases of carcinoid tumors. The same type of strong staining was seen in 4 (67{\%}) of 6 moderately differentiated neuroendocrine tumors. Only 2 (12{\%}) of 17 poorly differentiated neuroendocrine tumors showed similar staining. A strong, inverse correlation was seen with OCT4 and Ki-67 index. Immunoelectron microscopy showed binding of OCT4 antibody to neurosecretory granules. Cytoplasmic staining of OCT4 is a sensitive marker of neuroendocrine differentiation that has yet to be described in any other tissue or tumor type. These findings show that this antibody has a high affinity for well- to moderately differentiated neuroendocrine tumors. Although comparative studies with other markers and a more extensive analysis of other tissue types are necessary, cytoplasmic staining of OCT4 may prove to be a useful immunostain in the diagnosis of neuroendocrine tumors.",
keywords = "Carcinoid, Neuroendocrine tumors, OCT4, Small cell carcinoma",
author = "Alexander, {Riley E.} and Liang Cheng and Grignon, {David J.} and Idrees, {Muhammad T.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2013.08.006",
language = "English (US)",
volume = "45",
pages = "27--32",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Cytoplasmic OCT4 staining is a sensitive marker of neuroendocrine differentiation

AU - Alexander, Riley E.

AU - Cheng, Liang

AU - Grignon, David J.

AU - Idrees, Muhammad T.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Summary Previous studies by the authors have described a novel cytoplasmic staining pattern with OCT4 in normal adrenal medullary tissue and in paragangliomas. We aimed to determine if this type of staining is found in other neuroendocrine tissues by examining a broad range of neuroendocrine tumors. Fifty neuroendocrine tumors of various grades and primary organ sites were selected. All cases were immunostained with OCT4 and Ki-67. OCT4 reactivity was then scored for intensity (0-3+) and extent (0-3+). Ki-67 proliferation index was scored as a percentage of total tumor cells. Immunoelectron microscopy was performed to determine precise location of antibody binding within cells. Immunoreactivity was seen in 26 (96%) of 27 cases of carcinoid tumors. The same type of strong staining was seen in 4 (67%) of 6 moderately differentiated neuroendocrine tumors. Only 2 (12%) of 17 poorly differentiated neuroendocrine tumors showed similar staining. A strong, inverse correlation was seen with OCT4 and Ki-67 index. Immunoelectron microscopy showed binding of OCT4 antibody to neurosecretory granules. Cytoplasmic staining of OCT4 is a sensitive marker of neuroendocrine differentiation that has yet to be described in any other tissue or tumor type. These findings show that this antibody has a high affinity for well- to moderately differentiated neuroendocrine tumors. Although comparative studies with other markers and a more extensive analysis of other tissue types are necessary, cytoplasmic staining of OCT4 may prove to be a useful immunostain in the diagnosis of neuroendocrine tumors.

AB - Summary Previous studies by the authors have described a novel cytoplasmic staining pattern with OCT4 in normal adrenal medullary tissue and in paragangliomas. We aimed to determine if this type of staining is found in other neuroendocrine tissues by examining a broad range of neuroendocrine tumors. Fifty neuroendocrine tumors of various grades and primary organ sites were selected. All cases were immunostained with OCT4 and Ki-67. OCT4 reactivity was then scored for intensity (0-3+) and extent (0-3+). Ki-67 proliferation index was scored as a percentage of total tumor cells. Immunoelectron microscopy was performed to determine precise location of antibody binding within cells. Immunoreactivity was seen in 26 (96%) of 27 cases of carcinoid tumors. The same type of strong staining was seen in 4 (67%) of 6 moderately differentiated neuroendocrine tumors. Only 2 (12%) of 17 poorly differentiated neuroendocrine tumors showed similar staining. A strong, inverse correlation was seen with OCT4 and Ki-67 index. Immunoelectron microscopy showed binding of OCT4 antibody to neurosecretory granules. Cytoplasmic staining of OCT4 is a sensitive marker of neuroendocrine differentiation that has yet to be described in any other tissue or tumor type. These findings show that this antibody has a high affinity for well- to moderately differentiated neuroendocrine tumors. Although comparative studies with other markers and a more extensive analysis of other tissue types are necessary, cytoplasmic staining of OCT4 may prove to be a useful immunostain in the diagnosis of neuroendocrine tumors.

KW - Carcinoid

KW - Neuroendocrine tumors

KW - OCT4

KW - Small cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84890115227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890115227&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2013.08.006

DO - 10.1016/j.humpath.2013.08.006

M3 - Article

C2 - 24182453

AN - SCOPUS:84890115227

VL - 45

SP - 27

EP - 32

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 1

ER -